Wissenschaftliche Arbeiten

Prof. Dr. Meliha Nalçacı

176 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil
  1. Comparison of Total Leukocyte Chimerism and Lymphocyte Subset Chimerism for Early Detection of Post-Transplant Complications

    Transplant Immunology, 2026

    DOI 10.1016/j.trim.2026.102361 PMID 41672353 Quelle: OpenAlex

  2. Real-world effectiveness and safety of ruxolitinib in myelofibrosis: a multicenter cohort study (CHART-MF)

    Blood Global Hematology, 2026

    DOI 10.1016/j.bglo.2026.100162 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  3. Analysis of CALR-mutated essential thrombocythemia as a distinct disease entity compared with JAK2 V617F-mutated and triple-negative patients

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2026

    DOI 10.55730/1300-0144.6184 PMID 42058976 Frei zugänglicher VolltextQuelle: OpenAlex

  4. Cytogenetic Diversity of Variant Philadelphia Translocations in Chronic Myeloid Leukemia

    International Journal of Laboratory Hematology, 2026

    DOI 10.1111/ijlh.70146 PMID 42153575 Frei zugänglicher VolltextQuelle: OpenAlex

  5. IDH1 Mutations in Acute Myeloid Leukemia: Frequency and Clinical Features in the Context of FLT3 and NPM1 Co-Mutations—A Single-Center Study from Turkey

    Current Issues in Molecular Biology, 2026

    DOI 10.3390/cimb48080752 PMID 42651751 Frei zugänglicher VolltextQuelle: OpenAlex

  6. Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin’s Lymphoma: A Multi-Center Retrospective Study on Survival and Safety

    Indian Journal of Hematology and Blood Transfusion, 2025

    DOI 10.1007/s12288-025-02093-w PMID 42040698 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  7. CalR and MPL Driver Mutations and Their Role in the Diagnosis and Clinical Course of JAK2-Unmutated Chronic Myeloproliferative Neoplasm: Results from a Pilot Single-Center Study

    Medicina, 2025

    DOI 10.3390/medicina61060962 PMID 40572650 Frei zugänglicher VolltextQuelle: OpenAlex

  8. Congenital thrombotic thrombocytopenic purpura and human leukocyte antigen analysis–an amazing clue

    Hematology Transfusion and Cell Therapy, 2025

    DOI 10.1016/j.htct.2025.103746 PMID 39954327 Frei zugänglicher VolltextQuelle: OpenAlex

  9. Impact of COVID-19 on Hematologic Disorders: Clinical Insights and Challenges

    Istanbul Medical Journal, 2025

    DOI 10.4274/imj.galenos.2024.17092 Quelle: OpenAlex

  10. Novel prognostic factor in thrombotic thrombocytopenic purpura: human leukocyte antigen class II

    Blood Coagulation & Fibrinolysis, 2025

    DOI 10.1097/mbc.0000000000001372 PMID 40772348 Quelle: OpenAlex

  11. MİYELOFİBROZİSTE RUKSOLİTİNİBİN GERÇEK YAŞAM ETKİLİLİĞİ VE GÜVENLİLİĞİ: ÇOK MERKEZLİ KOHORT ÇALIŞMASI (CHART-MF)

    Kocaeli Üniversitesi - AVESİS, 2025

    Quelle: OpenAlex

  12. Brentuximab Vedotin Monotherapy in Relapsed/Refractory T Cell Lymphoma Setting-Real Life Data

    Hitit Medical Journal, 2024

    DOI 10.52827/hititmedj.1320606 Frei zugänglicher VolltextQuelle: OpenAlex

  13. Relationship between amide ratio assessed by Fourier‐transform infrared spectroscopy : A biomarker candidate for polycythemia vera disease

    Journal of Biophotonics, 2024

    DOI 10.1002/jbio.202400162 PMID 38978265 6 Zitationen (Europe PMC) Quelle: OpenAlex

  14. Identification of HLA alleles involved in immune thrombotic thrombocytopenic purpura patients from Turkey

    Blood Coagulation & Fibrinolysis, 2024

    DOI 10.1097/mbc.0000000000001318 PMID 39083057 4 Zitationen (Europe PMC) Quelle: OpenAlex

  15. Raman Spectroscopy of Blood Serum for Essential Thrombocythemia Diagnosis: Correlation with Genetic Mutations and Optimization of Laser Wavelengths

    Cell Biochemistry and Biophysics, 2024

    DOI 10.1007/s12013-024-01333-6 PMID 38847941 Quelle: OpenAlex

  16. CT-313 Long-Term Remission After Nelarabine and Donor Lymphocyte Infusion in a Patient With T-ALL Who Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation

    Clinical Lymphoma Myeloma & Leukemia, 2024

    DOI 10.1016/s2152-2650(24)01769-5 Quelle: OpenAlex

  17. CT-312 Secondary Solid Tumor After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report

    Clinical Lymphoma Myeloma & Leukemia, 2024

    DOI 10.1016/s2152-2650(24)01768-3 Quelle: OpenAlex

  18. SECONDARY SOLID CANCER FREQUENCY AND RISK FACTORS IN PHILADELPHIA- NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS

    Hematology Transfusion and Cell Therapy, 2024

    DOI 10.1016/j.htct.2024.04.005 Frei zugänglicher VolltextQuelle: OpenAlex

  19. The Incidence of BRAF V600E Mutations and the Impact of Cladribine Treatment on the Incidence of BRAF V600E Mutations and Survival in Hairy Cell Leukemia Patients: A Case-Control Study

    Turkiye Klinikleri Journal of Medical Sciences, 2024

    DOI 10.5336/medsci.2023-98368 Quelle: OpenAlex

  20. Secondary Solid Cancers Among Patients with Philadelphia Chromosome- Negative Myeloproliferative Neoplasms: A Multicenter Study

    Turkish Journal of Hematology, 2024

    DOI 10.4274/tjh.galenos.2024.2024.0199 PMID 39113479 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  21. MPN-176 Clinical Significance of CALR Mutation in Patients With Essential Thrombocythemia

    Clinical Lymphoma Myeloma & Leukemia, 2024

    DOI 10.1016/s2152-2650(24)01410-1 Quelle: OpenAlex

  22. Secondary Solid Tumor After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report

    Clinical Lymphoma Myeloma & Leukemia, 2024

    DOI 10.1016/s2152-2650(24)01048-6 Quelle: OpenAlex

  23. Long-Term Remission After Nelarabine and Donor Lymphocyte Infusion in a Patient With T-ALL Who Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation

    Clinical Lymphoma Myeloma & Leukemia, 2024

    DOI 10.1016/s2152-2650(24)01049-8 Quelle: OpenAlex

  24. Clinical Significance of CALR Mutation in Patients With Essential Thrombocythemia

    Clinical Lymphoma Myeloma & Leukemia, 2024

    DOI 10.1016/s2152-2650(24)00711-0 Quelle: OpenAlex

  25. Analysis of cerebrospinal fluid chimerism after hematopoietic stem cell transplantation: Case report

    Hematology Transfusion and Cell Therapy, 2024

    DOI 10.1016/j.htct.2024.04.129 PMID 39307621 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  26. Akut Miyeloid Lösemi’li Olgularda inv(3)/t(3;3) ile 7.Kromozomun Anomalilerinin Prognoza Etkisi

    Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, 2024

    DOI 10.34087/cbusbed.1406447 Quelle: OpenAlex

  27. Immunosuppression-Based Lymphoproliferative Disease Features and Parameters Affecting Survival

    Genel Tıp Dergisi, 2024

    DOI 10.54005/geneltip.1493721 Quelle: OpenAlex

  28. Real-Life Outcomes of Bosutinib in Patients with Chronic Myeloid Leukemia: A Multicenter Nationwide Study from Turkey

    Blood, 2024

    DOI 10.1182/blood-2024-193433 Frei zugänglicher VolltextQuelle: OpenAlex

  29. Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial

    The Lancet, 2023

    DOI 10.1016/s0140-6736(23)01460-5 PMID 37778358 83 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  30. Application of Fourier Transform InfraRed spectroscopy of machine learning with Support Vector Machine and principal components analysis to detect biochemical changes in dried serum of patients with primary myelofibrosis

    Biochimica et Biophysica Acta (BBA) - General Subjects, 2023

    DOI 10.1016/j.bbagen.2023.130438 PMID 37516257 7 Zitationen (Europe PMC) Quelle: OpenAlex

  31. FTIR- based serum structure analysis in molecular diagnostics of essential thrombocythemia disease

    Journal of Photochemistry and Photobiology B Biology, 2023

    DOI 10.1016/j.jphotobiol.2023.112734 PMID 37295134 8 Zitationen (Europe PMC) Quelle: OpenAlex

  32. Comprehensive mastocytosis data analysis from a single center

    BMC Cancer, 2023

    DOI 10.1186/s12885-022-10498-3 PMID 36694141 5 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  33. Detection of primary myelofibrosis in blood serum via Raman spectroscopy assisted by machine learning approaches; correlation with clinical diagnosis

    Nanomedicine Nanotechnology Biology and Medicine, 2023

    DOI 10.1016/j.nano.2023.102706 PMID 37633405 2 Zitationen (Europe PMC) Quelle: OpenAlex

  34. Clinical Impact of JAK2V617F Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms

    Turkish Journal of Hematology, 2023

    DOI 10.4274/tjh.galenos.2023.2023.0169 PMID 37584526 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  35. Raman spectroscopy-based biomarker screening by studying the fingerprint and lipid characteristics of Polycythem..a Vera cases blood serum

    Photodiagnosis and Photodynamic Therapy, 2023

    DOI 10.1016/j.pdpdt.2023.103572 PMID 37060986 5 Zitationen (Europe PMC) Quelle: OpenAlex

  36. P939: THE RELATIONSHIP OF BONE MARROW FIBROSIS WITH EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA

    HemaSphere, 2023

    DOI 10.1097/01.hs9.0000970660.09840.e4 Quelle: OpenAlex

  37. Baseline inflammation indexes and neutrophil‐to‐LDH ratio for prediction of the first mobilization failure without plerixafor‐based regimens in multiple myeloma and lymphoma patients: A single‐center retrospective study

    Journal of Clinical Apheresis, 2023

    DOI 10.1002/jca.22085 PMID 37574922 2 Zitationen (Europe PMC) Quelle: OpenAlex

  38. Successful Management of Ibrutinib-Induced Thrombocytopenia in a Patient with Chronic Lymphocytic Leukemia: No Interruption, Only Reduction

    Turkish Journal of Hematology, 2023

    DOI 10.4274/tjh.galenos.2023.2023.0426 PMID 38131309 Frei zugänglicher VolltextQuelle: OpenAlex

  39. Comparison of different plerixafor-based strategies for adequate hematopoietic stem cell collection in poor mobilizers

    The European Research Journal, 2023

    DOI 10.18621/eurj.1231251 Frei zugänglicher VolltextQuelle: OpenAlex

  40. CLL-079 The Effect of T-Lymphocyte Subgroups at Diagnosis on the Prognosis of Chronic Lymphocytic Leukemia (CLL)

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)01095-9 Quelle: OpenAlex

  41. POSTER: CT-236 Scabies Induced Hypereosinophilic Syndrome After Allogeneic Stem Cell Transplant: Case Report

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)00920-5 Quelle: OpenAlex

  42. POSTER: CT-128 Impact of Epitope Match on Stem Cell Transplantation

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)00915-1 Quelle: OpenAlex

  43. MM-224 A Rare Case of Multiple Myeloma Presenting as a Cranial Nerve Palsy

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)01420-9 Quelle: OpenAlex

  44. CT-128 Impact of Epitope Match on Stem Cell Transplantation

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)01489-1 Quelle: OpenAlex

  45. MPN-227 Insight into Hypereosinophilia from the Hematology Clinic; A Single-Center Experience

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)01228-4 Quelle: OpenAlex

  46. POSTER: MM-224 A Rare Case of Multiple Myeloma Presenting as a Cranial Nerve Palsy

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)00870-4 Quelle: OpenAlex

  47. POSTER: MPN-140 The Role of 18F-FDG PET/CT Scan in Adult Langerhans Cell Histiocytosis: A Single-Center Experience

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)00633-x Quelle: OpenAlex

  48. POSTER: MPN-227 Insight into Hypereosinophilia from the Hematology Clinic; A Single-Center Experience

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)00638-9 Quelle: OpenAlex

  49. MPN-140 The Role of 18F-FDG PET/CT Scan in Adult Langerhans Cell Histiocytosis: A Single-Center Experience

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)01223-5 Quelle: OpenAlex

  50. CT-236 Scabies Induced Hypereosinophilic Syndrome After Allogeneic Stem Cell Transplant: Case Report

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)01503-3 Frei zugänglicher VolltextQuelle: OpenAlex